The costs associated with lung volume reduction surgery will be covered by the US Center for Medicare and Medicaid Services for US patients with emphysema who fulfil coverage criteria

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.428, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Value of lung volume-reduction surgery in emphysema uncertain

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 414, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Etanercept or infliximab: costs to US Medicare

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 276, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Etanercept or infliximab: costs to US Medicare

By  

Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Extending US Medicare coverage worth it in kidney transplantation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Drug coverage among US Medicare Part D formularies in California varies substantially, although the majority of treatment classes have at least one widely covered drug

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 531, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite